Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Blue Cross and Blue Shield of Kansas, Inc.

2. Address

Address1
1133 S.W. Topeka Blvd.
 Address2
​
City
Topeka
 State
KS
 Zip Code
66629-0001
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Sunee Mickle
​7852917194
​sunee.mickle@bcbsks.com
5. Senate ID#
​323876-12
7. Client Name Self Check if client is a state or local government or instrumentality
​Blue Cross and Blue Shield of Kansas, Inc.
6. House ID#
​397350000
TYPE OF REPORT 8. Year
​2020
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Sunee Mickle
 Date
4/17/2020 12:18:03 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Affordable Care Act (ACA);Affordability, ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; SNP's; 42 CFR Part 2; Transparency; Silverloading; Interoperability; Health IT; Surprise Billing; Small Business; Biosimilars; Prior Authorization; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; All Payer Claims Databases; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In, Texas lawsuit, Transparency, State Flexibility, Social determinants of health, Community Health, Cybersecurity, NBPP(Notice Benefit and Payment Parameters);Consumer-Facing app disclosures; Provider directories; Maternal Health; Senior's health care; COVID-19 Response/Relief Packages; Healthcare access/privacy.

H.R. 1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7](Introduced 2/27/19)

H.R. 2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 04/01/2019)

H.R. 2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 04/01/2019)

S. 973 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Sen Smith, Tina [D_MN](Introduced 04/01/2019)

S. 971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D_MN](Introduced 04/01/2019)

S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 6/19/2019)

H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)

H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)

H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S.,Jr. [D-VA-8](Introduced 06/24/2019)

S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 06/19/2019)

H.R.2774 - 116th Congress (2019-2020)
Primary Care Patient Protection Act of 2019
Sponsor: Rep. Schneider, Brad [D-IL-10](Introduced 05/15/2019)

H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)

S.3548 - 116th Congress (2019-2020)
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. McConnell, Mitch [R-KY](Introduced 03/19/2020)

H.R.5754 - 116th Congress (2019-2020)
Rural ER Access Act
Sponsor: Rep. Green, Mark [R-TN-7](Introduced 02/04/2020)

H.R.5800 - 116th Congress (2019-2020)
Ban Surprise Billing Act
Sponsor: Rep. Scott, Robert [D-VA-3](Introduced 02/07/2020)

H.R.6201 - 116th Congress (2019-2020)
Families First Coronavirus Response Act
Sponsor: Rep. Lowey, Nita [D-NY-17](Introduced 03/11/2020)

H.R.2064 - 116th Congress (2019-2020)
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes
Sponsor: Rep. Chu, Judy [D-CA-27](Introduced 04/03/2020)

H.R.6311 - 116th Congress (2019-2020)
Care for COVID-19 Act
Sponsor: Rep. Ruiz, Raul [D-CA-36](Introduced 03/19/2020)

H.R.6299 - 116th Congress (2019-2020)
Rapid Coverage of COVID-19 Vaccine Act of 2020
Sponsor: Rep. Courtney, joe[D-CT-2](Introduced 03/19/2020)

H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1](Introduced 02/10/2020)

H.R.6244 - 116th Congress (2019-2020)
To amend titles XVIII and XIX to provide for coverage at no cost sharing of COVID-19 testing under the Medicaid program and Children's Health Insurance Program.
Sponsor: Rep. Kelly, Robin [D-IL-2](Introduced 03/12/2020)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Sunee
Mickle
​
Vice President of Government and Community Relations

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicare Advantage; Medicaid Rebates; Medicaid Expansion; Medicaid General; Medicare Prior Authorization; MACRA; Rate Notice and Call Letter; NBPP; Medicare Part D Rx Rebates, Medicare Data Sharing; Privacy; Medicare Prescription Drug Pricing; CMS Program Integrity Rule; Generic drugs (CREATES); Drug approval; HELP Cost reduction package; CHIP; Provider funding

H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)

H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large](Introduced 01/08/2019)

H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Sunee
Mickle
​
Vice President of Government and Community Relations

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s; Tax Extenders

H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.

H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)

H.R.2774 - 116th Congress (2019-2020)
Primary Care Patient Protection Act of 2019
Sponsor: Rep Schneider, Brad [D-IL-10](Introduced 05/15/2019)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Sunee
Mickle
​
Vice President of Government and Community Relations

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Rx Rebates; Biosimilars; Drug approval; Drug patents, generic drugs, Part D Reform; Civica Rx

H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby [D-IL-1](Introduced 03/08/2019)

H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David [D-RI-1](Introduced 02/05/2019)

H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)

H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Action of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large](Introduced 01/08/2019)

H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)

H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)

S.3092 - 116th Congress (2019-2020)
Expanding Access to Low-Cost Generics Act of 2019
Sponsor: Sen. Smith, Tina [D-MN](Introduced 12/18/2019)

H.R.19 - 116th Congress (2019-2020)
Lower Costs, More Cures Act of 2019
Sponsor: Rep. Walden, Gred [R-OR-2](Introduced 12/09/2019)

H.R.6193 - 116th Congress (2019-2020)
Medication Access in Emergencies Act of 2020
Sponsor: Rep Pappas, Chris [D-NH-1](Introduced 03/11/2020)

H.R.5578 - 116th Congress (2019-2020)
Recall Unsafe Drugs Act of 2020
Sponsor: Rep. Delauro, Rosa [D-CT-3](Introduced 01/10/2020)

H.R.5691 - 116th Congress (2019-2020)
Insulin Affordability Data Collection Act
Sponsor: Rep. Craig, Angie [D-MN-2](Introduced 01/28/2020)

H.R.5894 - 116th Congress (2019-2020)
Transparency in Prescription Drug Advertising Act
Sponsor: Rep Davids, Sharice [D-KS-3](Introduced 02/13/2020)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Sunee
Mickle
​
Vice President of Government and Community Relations

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​PHA
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)